|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$96,692.10 |
3.11% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$84,409.57 |
2.71% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$80,412.51 |
2.58% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$79,678.26 |
2.56% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$77,512.40 |
2.49% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$75,699.54 |
2.43% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$74,257.89 |
2.39% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$73,897.92 |
2.37% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$72,087.55 |
2.32% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$71,717.40 |
2.30% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$71,069.58 |
2.28% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$70,623.81 |
2.27% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$70,296.92 |
2.26% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$69,898.14 |
2.25% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$69,570.60 |
2.24% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$69,368.70 |
2.23% |
| Waters Corporation |
WAT |
941848103 |
184 |
$68,952.16 |
2.22% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$67,735.54 |
2.18% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$67,236.74 |
2.16% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$65,255.68 |
2.10% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$65,020.22 |
2.09% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$65,025.00 |
2.09% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$63,241.64 |
2.03% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$62,986.56 |
2.02% |
| Steris Plc |
STE |
G8473T100 |
265 |
$61,649.60 |
1.98% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$61,225.00 |
1.97% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$61,462.44 |
1.97% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$61,388.34 |
1.97% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$60,080.17 |
1.93% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$59,368.80 |
1.91% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$59,013.81 |
1.90% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$58,782.60 |
1.89% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$58,595.68 |
1.88% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$58,473.97 |
1.88% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$57,497.56 |
1.85% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$56,507.35 |
1.82% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$56,272.11 |
1.81% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$55,519.02 |
1.78% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$54,236.42 |
1.74% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$53,111.92 |
1.71% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$53,255.54 |
1.71% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$52,964.65 |
1.70% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$50,910.00 |
1.64% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$48,803.30 |
1.57% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$47,096.86 |
1.51% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$46,380.80 |
1.49% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$46,250.65 |
1.49% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,686.02 |
1.44% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$41,070.87 |
1.32% |
| US Dollar |
$USD |
|
14,998 |
$14,997.80 |
0.48% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|